Microfluidic Model to Mimic Initial Event of Neovascularization
April 10th, 2021
4.3K views
Here, we provide a microfluidic chip and an automatically controlled, highly efficient circulation microfluidic system that recapitulates the initial microenvironment of neovascularization, allowing endothelial cells (ECs) to be stimulated by high luminal shear stress, physiological level of transendothelial flow, and various vascular endothelial growth factor (VEGF) distribution simultaneously.
Overview
This article presents the development of an in vitro 3D microfluidic model that replicates the initial stages of neovascularization under physiological conditions. The model, termed MIEN, integrates a microfluidic sprouting chip and an automated circulation system to simulate the biomechanical and biochemical microenvironment of endothelial cells (ECs) during early neovascularization. This platform enables precise control of luminal shear stress, transendothelial flow, and vascular endothelial growth factor (VEGF) gradients, providing a valuable tool for mechanistic studies and drug screening.
Key Study Components
Area of Science
- Vascular biology
- Tissue engineering
- Microfluidics
Background
- Neovascularization is the formation of new blood vessels from existing vasculature, crucial in both physiological and pathological contexts.
- The initial microenvironment experienced by ECs during neovascularization differs significantly from later stages.
- Existing models often fail to accurately mimic the early biomechanical and biochemical conditions of neovascularization.
- There is a need for in vitro systems that recapitulate these initial events for mechanistic and translational research.
Purpose of Study
- To develop a 3D in vitro model that simulates the initial process of neovascularization under physiological microenvironmental conditions.
- To enable controlled application of shear stress, transendothelial flow, and VEGF gradients to ECs.
- To provide a platform suitable for mechanistic studies and drug/toxicology screening.
Methods Used
- Fabrication of a microfluidic sprouting chip with three channels: an EC culture channel, a central hydrogel channel, and a liquid channel.
- Coating of channels with fibronectin and seeding of endothelial cells to form a confluent endothelium.
- Assembly of an automated microfluidic control system including syringe and peristaltic pumps, bubble trap, and programmable flow control.
- Application of controlled luminal shear stress, physiological transendothelial flow, and VEGF gradients.
- Assessment of vessel barrier function via FITC-dextran permeability assays.
- Quantification of endothelial sprouting under varying shear stress conditions.
Main Results
- The model successfully formed perfusable, endothelialized microchannels mimicking early neovascularization.
- Barrier function was demonstrated by low permeability coefficients in cell-lined channels compared to empty channels.
- Endothelial sprouting into the hydrogel was observed after 24 hours of static culture.
- Increasing luminal shear stress significantly reduced the extent and length of endothelial sprouting.
- The system allowed dynamic modulation of shear stress while maintaining physiological transendothelial flow.
Conclusions
- The MIEN model effectively recapitulates the initial microenvironment of neovascularization in vitro.
- Shear stress is a key regulator of endothelial sprouting in this context.
- This platform is promising for mechanistic studies of neovascularization and as a low-cost tool for drug screening and toxicology.
Frequently Asked Questions
What is the main advantage of the MIEN model over previous neovascularization models?
The MIEN model uniquely replicates the initial physiological microenvironment of neovascularization, allowing precise control of shear stress, transendothelial flow, and VEGF gradients, which are difficult to achieve simultaneously in other models.
How is the endothelial barrier function assessed in this system?
Barrier function is evaluated by measuring the diffusional permeability coefficient of 40 kDa FITC-dextran across the endothelialized microchannel, with lower permeability indicating better barrier integrity.
How does shear stress affect endothelial sprouting in the MIEN model?
Increased luminal shear stress significantly decreases both the area and length of endothelial sprouting into the hydrogel, demonstrating its inhibitory effect on early neovascularization events.
What components make up the microfluidic control system?
The system includes a microsyringe pump, electromagnetic pinch valve, bubble trap chip, micro-peristaltic pump, and a culture medium reservoir, all connected via tubing and controlled by a custom program.
Can the MIEN model be used for drug screening?
Yes, the model's ability to mimic physiological conditions and allow dynamic control of microenvironmental factors makes it suitable for drug screening and toxicology studies related to neovascularization.
What is the significance of using a 3D hydrogel channel in the chip?
The 3D hydrogel channel provides a biomimetic extracellular matrix environment, enabling realistic endothelial sprouting and vessel formation similar to in vivo conditions.
Is the system compatible with real-time observation and manipulation?
Yes, the microfluidic setup allows for real-time imaging and dynamic adjustment of flow parameters, facilitating detailed mechanistic studies.
Executive Industry Relevance
Early-stage neovascularization modeling is critical for de-risking vascular target hypotheses and optimizing predictive confidence in drug discovery pipelines. The MIEN microfluidic platform enables precise simulation of the initial vascular microenvironment, supporting mechanistic interrogation and quantitative assessment of endothelial responses. This capability enhances translational continuity and informs portfolio triage for vascular-targeted therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic de-risking of vascular targets by replicating physiological shear stress and VEGF gradients.
- Supports functional validation of endothelial cell behavior under controlled microenvironmental conditions.
- Facilitates predictive confidence in early-stage vascular biology hypotheses.
Screening & Assay Development
- Provides a standardized, reproducible 3D assay platform for evaluating compound effects on endothelial sprouting.
- Generates quantitative outputs such as permeability coefficients and sprouting metrics for robust comparison.
- Enables scalable screening of drug candidates and toxicology profiles in a physiologically relevant context.
Translational & Preclinical Research
- Aligns in vitro findings with disease-relevant vascular mechanisms for improved translational biomarker strategies.
- Supports continuity from discovery through preclinical validation by modeling early neovascularization events.
- Reduces biological ambiguity in preclinical advancement decisions for vascular-targeted programs.
Pipeline & Workflow Integration
The MIEN model integrates into the discovery-to-preclinical continuum by enabling hypothesis testing, quantitative screening, and mechanistic validation of vascular targets.
- Discovery Biology: Supports pathway clarification and biological de-risking through controlled microenvironmental manipulation.
- Screening: Delivers reproducible, quantitative metrics for compound evaluation and assay standardization.
- Analytics: Provides permeability and sprouting readouts to compare experimental conditions and inform decision-making.
- Translational Research: Bridges in vitro mechanistic insights with preclinical vascular models when aligned with disease relevance.
- Enterprise Reuse: Functions as a reusable platform for diverse vascular biology and drug screening applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular target validation.
- Operational Value: Standardizes endothelial assays and supports reproducibility across R&D teams.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by de-risking early-stage vascular programs.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of vascular-targeted assets.
Implementation Considerations
- Requires expertise in microfluidics, endothelial cell culture, and quantitative assay analysis.
- Needs access to programmable pumps, microfluidic chips, and imaging infrastructure.
- Demands cross-team standardization of assay setup and data interpretation.
- Adaptation may be needed for different endothelial cell sources or disease models.
- Limitations include throughput constraints and the need for specialized technical training.
Biopharma FAQs
Why does null hypothesis testing matter for endothelial sprouting assays?
Null hypothesis testing in the MIEN model enables objective evaluation of whether observed changes in endothelial sprouting are statistically significant under defined shear stress or VEGF conditions, supporting robust target validation decisions.
How does independent variable isolation fit the microfluidic neovascularization workflow?
The MIEN platform allows precise isolation and modulation of variables such as shear stress and VEGF gradients, enabling systematic dissection of their individual effects on endothelial behavior within the discovery pipeline.
What do quantitative permeability and sprouting measurements enable in R&D?
Quantitative outputs like permeability coefficients and sprouting metrics provide actionable data for comparing experimental conditions, optimizing assay parameters, and informing compound selection in early-stage screening.
Why are replication requirements critical for cross-functional vascular studies?
Replication ensures that observed endothelial responses to microenvironmental changes are reproducible and reliable, facilitating cross-team data integration and collaborative decision-making in vascular biology programs.
What statistical analysis capabilities are required before MIEN model implementation?
Teams must be equipped to perform statistical comparisons of permeability and sprouting data, ensuring that experimental findings meet rigor and reproducibility standards for downstream R&D applications.
![Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F54014.jpg%3Fv%3D2026-08-26T10%253A21%253A11.000Z&w=384&q=75)
